Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine add-on to leuprorelin for endometriosis-related chronic pelvic pain
2008-008722-73Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Mar 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of paroxetine and leuprolide in endometriosis and chronic prostatitis (CP) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Reduction in endometriosis-related pelvic pain. Started Mar 2009; status: active.
02
Drugs
paroxetineleuprolide
03
Conditions
endometriosischronic prostatitis (CP)
Beyond the preview
Go deeper on 2008-008722-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008722-73.